NIH-funded research R01 grant

Better Lung Cancer Screening for Cancer Survivors

Official title: Optimizing Lung Cancer Screening in Cancer Survivors

Funded at Icahn School of Medicine at Mount Sinai · NIH-11115848 · Data updated 2026-11-12

This project aims to find the best ways to screen for lung cancer in people who have previously had breast, prostate, or colorectal cancer.

More Lung Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 15, 2021
Project endJune 30, 2026
Funding year2025
Award (this year)$688,469
NIH project number5R01CA264995-05
Project IDNIH-11115848 on NIH RePORTER

Who could benefit from this research

Could help

This research is relevant for individuals who have survived breast, prostate, or colorectal cancer and are at risk for developing lung cancer.

Less likely to help

Patients who have not had breast, prostate, or colorectal cancer may not directly benefit from the specific screening strategies identified by this research.

What this research studies

Many people who have survived breast, prostate, or colorectal cancer live long lives, but they face a higher risk of developing a second cancer, especially lung cancer. This is because of factors like past smoking habits, age, and side effects from their previous cancer treatments. Currently, we don't have clear guidelines for lung cancer screening in this group, as they were often not included in past screening studies. This project will create a computer model to understand how lung cancer develops and progresses in diverse groups of cancer survivors. We will then use this model to figure out which screening methods are most effective and cost-efficient for them.

Why it matters

Potential benefit: If successful, this work could lead to improved guidelines for lung cancer screening, helping cancer survivors detect lung cancer earlier and potentially improving their outcomes.

How similar studies have gone: Prior randomized trials have not specifically focused on lung cancer screening in cancer survivors, making this a novel approach to address a gap in current knowledge.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Wisnivesky, Juan P — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Wisnivesky, Juan P

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.